[PDF][PDF] 肝癌免疫微环境与免疫治疗: 研究进展与发展趋势
邹添添， 覃伟， 朱迎， 李天恩， 钦伦秀， 董琼珠 - 中国普通外科杂志, 2020 - zpwz.net
The tumor microenvironment in hepatocellular carcinoma (HCC) comprises a variety of cell
types that include tumor-associated macrophages, tumor-associated neutrophils, myeloid …
types that include tumor-associated macrophages, tumor-associated neutrophils, myeloid …
肝癌免疫微环境与免疫治疗研究进展
李江， 黄志勇 - 临床外科杂志, 2021 - lcwkzz.com
肝癌是最常见的恶性肿瘤之一, 多种因素可导致肝癌的发生和发展. 免疫微环境的变化可能在
肝癌的复发转移, 免疫抵抗和免疫逃逸中发挥重要作用. 近年来, 以免疫节点抑制剂 …
肝癌的复发转移, 免疫抵抗和免疫逃逸中发挥重要作用. 近年来, 以免疫节点抑制剂 …
[PDF][PDF] 肝癌免疫微环境及免疫治疗最新进展
何其宽， 叶志宇， 陈晓岗 - 肝胆胰外科杂志, 2020 - gdy.qk.wmu.edu.cn
肝细胞肝癌(hepatocellular carcinoma, HCC) 作为最常见的原发性肝癌(占70%~ 90%),
据统计全球每年新增HCC 至少有70 万例[1], 仅我国就占到了其中一半. HCC …
据统计全球每年新增HCC 至少有70 万例[1], 仅我国就占到了其中一半. HCC …
The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook
Z Zhou, Y Hu, Y Wu, Q Qi, J Wang, L Chen… - Molecular Immunology, 2022 - Elsevier
Hepatocellular carcinoma (HCC) is one of the most severe malignant tumors that threaten
human health, and its incidence is still on the rise recently. In spite of the current emerging …
human health, and its incidence is still on the rise recently. In spite of the current emerging …
Immunological microenvironment of hepatocellular carcinoma and its clinical implication
N Nishida, M Kudo - Oncology, 2017 - karger.com
Despite recent advances in the treatment of hepatocellular carcinoma (HCC), the prognosis
of patients with advanced stage of disease remains unfavorable. Several immune therapies …
of patients with advanced stage of disease remains unfavorable. Several immune therapies …
Deciphering the tumour immune microenvironment of hepatocellular carcinoma
S Liu, M Jia, R Dai - Scandinavian Journal of Immunology, 2023 - Wiley Online Library
Current treatments for hepatocellular carcinoma (HCC) are less effective and prone to
recurrence after surgery, so it's needed to seek new ideas for its therapy. Tumour immune …
recurrence after surgery, so it's needed to seek new ideas for its therapy. Tumour immune …
[PDF][PDF] The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma
ZY Feng, FG Xu, Y Liu, HJ Xu, FB Wu… - Hepatoma …, 2021 - pdfs.semanticscholar.org
Hepatocellular carcinoma (HCC) accounts for 75%-85% of all primary liver cancers and is
the leading cause of cancer-related deaths. China accounts for almost half of the global …
the leading cause of cancer-related deaths. China accounts for almost half of the global …
[PDF][PDF] Recent advances regarding tumor microenvironment and immunotherapy in hepatocellular carcinoma
W Qin, ZY Cao, SY Liu, XD Xu - Hepatoma Res, 2020 - pdfs.semanticscholar.org
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the liver,
with poor prognosis and high mortality. Traditional treatments for patients with HCC have …
with poor prognosis and high mortality. Traditional treatments for patients with HCC have …
Tumor microenvironment in hepatocellular carcinoma: key players for immunotherapy
H Feng, Y Zhuo, X Zhang, Y Li, Y Li… - Journal of …, 2022 - Taylor & Francis
Hepatocellular carcinoma (HCC) remains a serious medical therapeutic challenge as
conventional curative avenues such as surgery and chemotherapy only benefit for few …
conventional curative avenues such as surgery and chemotherapy only benefit for few …
[HTML][HTML] Hepatocellular carcinoma tumor microenvironment and its implications in terms of anti-tumor immunity: Future perspectives for new therapeutics
Purpose Hepatocellular cancer is an insidious tumor that is often diagnosed in a later stage
of life. The tumor microenvironment is the key to tumorigenesis and progression. Many …
of life. The tumor microenvironment is the key to tumorigenesis and progression. Many …